JENNIFER SHELDON: Open Payments
NPI 1548692700 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,242 in 119 payments from 27 companies in 2025. Trend: 2023 $1,948 · 2024 $2,260 · 2025 $2,242
Food & beverage: $2,242
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $435 |
| Amgen Inc. | 20 | $262 |
| Lilly USA, LLC | 15 | $198 |
| Insulet Corporation | 8 | $175 |
| Novartis Pharmaceuticals Corporation | 12 | $155 |
| Corcept Therapeutics | 5 | $98 |
| SANOFI-AVENTIS U.S. LLC | 4 | $97 |
| CeQur Corporation | 1 | $80 |
| Radius Health, Inc. | 3 | $77 |
| Abbott Laboratories | 4 | $71 |
Products named: Ozempic, TEPEZZA, Omnipod, LEQVIO, MOUNJARO, Korlym, TZIELD, CeQur Simplicity.
Industry payments across GA — which companies pay providers there.
